| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040851222 |
| P356 | DOI | 10.1186/1475-2840-11-153 |
| P932 | PMC publication ID | 3549933 |
| P698 | PubMed publication ID | 23259529 |
| P5875 | ResearchGate publication ID | 233972842 |
| P50 | author | Franca Marino | Q88230297 |
| Marco Cosentino | Q42388788 | ||
| Andrea Maria Maresca | Q43148515 | ||
| Luigina Guasti | Q57018772 | ||
| P2093 | author name string | Francesco Dentali | |
| Emanuela Rasini | |||
| Massimiliano Legnaro | |||
| Laura Schembri | |||
| Anna Maria Grandi | |||
| Christian Mongiardi | |||
| Luana Castiglioni | |||
| Ramona C Maio | |||
| P2860 | cites work | Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome | Q79165981 |
| Angiotensin receptors and aging | Q80280882 | ||
| Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis | Q80968903 | ||
| Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients | Q24324656 | ||
| Cross-talk between angiotensin II receptor types 1 and 2: potential role in vascular remodeling in humans | Q24324723 | ||
| Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries | Q24338401 | ||
| Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. | Q30436078 | ||
| Cytokines in atherosclerosis: pathogenic and regulatory pathways | Q34511711 | ||
| Pharmacological and non-pharmacological interventions to influence adipose tissue function. | Q34576535 | ||
| Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells | Q34650855 | ||
| Role of Monocytes in Atherogenesis | Q35541858 | ||
| Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds | Q36424501 | ||
| C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus | Q36832818 | ||
| Mouse models for atherosclerosis and pharmaceutical modifiers. | Q36836487 | ||
| The macrophage at the crossroads of insulin resistance and atherosclerosis | Q36843648 | ||
| Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors | Q36918543 | ||
| Changes of gene expression profiles in macrophages stimulated by angiotensin II--angiotensin II induces MCP-2 through AT1-receptor | Q40135319 | ||
| Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection | Q42933669 | ||
| The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse. | Q43017133 | ||
| Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. | Q44063984 | ||
| Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome | Q46136981 | ||
| Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and T lymphocytes. | Q46599107 | ||
| Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up | Q46663053 | ||
| Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation | Q46695861 | ||
| The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning | Q46732997 | ||
| Role of blood cell-associated AT1 receptors in the microvascular responses to hypercholesterolemia | Q46778202 | ||
| Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis | Q46810855 | ||
| Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease | Q46874077 | ||
| Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. | Q46986151 | ||
| Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. | Q54250247 | ||
| Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma. | Q54567108 | ||
| The increased angiotensin II (type 1) receptor density in myocardium of type 2 diabetic patients is prevented by blockade of the renin-angiotensin system. | Q54575575 | ||
| The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease | Q56867091 | ||
| Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study | Q57786382 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypercholesterolemia | Q762713 |
| P304 | page(s) | 153 | |
| P577 | publication date | 2012-12-22 | |
| P1433 | published in | Cardiovascular Diabetology | Q2468083 |
| P1476 | title | Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment | |
| P478 | volume | 11 |
| Q41348051 | Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hyp |
| Q36797594 | Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway |
| Q24187891 | Lipid-lowering efficacy of rosuvastatin |
| Q35907898 | Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment |
| Q37712597 | Simvastatin treatment attenuates increased respiratory variability and apnea/hypopnea index in rats with chronic heart failure |
| Q54605224 | Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease. |
| Q64237521 | sRAGE and early signs of cardiac target organ damage in mild hypertensives |
Search more.